1 | stable | 11,368 |
2 | dialysis-dependent | 36 |
3 | non-dialysis-dependent | 33 |
4 | unhealed | 24 |
5 | instable | 21 |
6 | rejection-free | 19 |
7 | one-vessel | 18 |
8 | scbc | 17 |
9 | submsv | 13 |
10 | well-adjusted | 9 |
11 | malaria-free | 7 |
12 | stabile | 7 |
13 | bulk-like | 6 |
14 | chronic-progressive | 5 |
15 | grn+ | 5 |
16 | motionless | 5 |
17 | 2,856 | 4 |
18 | interepisode | 4 |
19 | lay-facilitated | 4 |
20 | pbo/fin | 4 |
21 | co-inherited | 3 |
22 | controlled/cured | 3 |
23 | mg-positive | 3 |
24 | non-resistant | 3 |
25 | quasi-equilibrium | 3 |
26 | 200-µm | 2 |
27 | angiographically-proven | 2 |
28 | a→c | 2 |
29 | complicated/severe | 2 |
30 | early/severe | 2 |
31 | endogenous/psychotic | 2 |
32 | nephrocardiovascular | 2 |
33 | nonmobile | 2 |
34 | oxygen-permeable | 2 |
35 | renoparenchymal | 2 |
36 | second-reader | 2 |
37 | toraymyxin | 2 |
38 | vasoproliferative | 2 |
39 | 0g/d | 1 |
40 | 1.15±0.59 | 1 |
41 | 11,292 | 1 |
42 | 13,880 | 1 |
43 | 18f-fallypride | 1 |
44 | 193.19±68.96 | 1 |
45 | 2.84±2.07 | 1 |
46 | 26-bed | 1 |
47 | 277/465 | 1 |
48 | 34,912 | 1 |
49 | 4-chloro-3,5-dinitrobenzotrifluoride | 1 |
50 | 44ca | 1 |
51 | 474.63±108.50 | 1 |
52 | 5.08±2.76 | 1 |
53 | age-hardenability | 1 |
54 | attagel | 1 |
55 | back-symptoms | 1 |
56 | caries-onset | 1 |
57 | ccs≥10 | 1 |
58 | cf3i | 1 |
59 | diet-alone-treated | 1 |
60 | ebook | 1 |
61 | effort-associated | 1 |
62 | elastase-dependent | 1 |
63 | encephalography | 1 |
64 | glucagon/insulin | 1 |
65 | haemodialysis-dependent | 1 |
66 | hyperoxic-hypoxic | 1 |
67 | hypo-adiponectinemia | 1 |
68 | indo- | 1 |
69 | ionomycin/6-dimethylaminopurine | 1 |
70 | ipp=20mmhg | 1 |
71 | irbersartan | 1 |
72 | iss/8 | 1 |
73 | latrr | 1 |
74 | liver-cells | 1 |
75 | lt-4 | 1 |
76 | macrolide-recipients | 1 |
77 | magical-energetic | 1 |
78 | men1-related | 1 |
79 | non-invalidating | 1 |
80 | noncongenital | 1 |
81 | nondialysis-requiring | 1 |
82 | nonequilibrated | 1 |
83 | nonrecruited | 1 |
84 | non–dialysis-requiring | 1 |
85 | ns3-r155k | 1 |
86 | oligo/amenorrhoea | 1 |
87 | overbidding | 1 |
88 | pars-planitis | 1 |
89 | phio | 1 |
90 | phospho-hsf1 | 1 |
91 | promus™ | 1 |
92 | r2-f. | 1 |
93 | risperi-done | 1 |
94 | spirometry-defined | 1 |
95 | squatters | 1 |
96 | subcapsulary | 1 |
97 | surgery-on | 1 |
98 | tempo/speed | 1 |
99 | tnfα-blockers | 1 |
100 | tocopherol-based | 1 |
101 | unstable/postinfarction | 1 |
102 | was-out | 1 |
1 | 0g/d | 1 |
2 | 1.15±0.59 | 1 |
3 | 11,292 | 1 |
4 | 13,880 | 1 |
5 | 18f-fallypride | 1 |
6 | 193.19±68.96 | 1 |
7 | 2,856 | 4 |
8 | 2.84±2.07 | 1 |
9 | 200-µm | 2 |
10 | 26-bed | 1 |
11 | 277/465 | 1 |
12 | 34,912 | 1 |
13 | 4-chloro-3,5-dinitrobenzotrifluoride | 1 |
14 | 44ca | 1 |
15 | 474.63±108.50 | 1 |
16 | 5.08±2.76 | 1 |
17 | age-hardenability | 1 |
18 | angiographically-proven | 2 |
19 | attagel | 1 |
20 | a→c | 2 |
21 | back-symptoms | 1 |
22 | bulk-like | 6 |
23 | caries-onset | 1 |
24 | ccs≥10 | 1 |
25 | cf3i | 1 |
26 | chronic-progressive | 5 |
27 | co-inherited | 3 |
28 | complicated/severe | 2 |
29 | controlled/cured | 3 |
30 | dialysis-dependent | 36 |
31 | diet-alone-treated | 1 |
32 | early/severe | 2 |
33 | ebook | 1 |
34 | effort-associated | 1 |
35 | elastase-dependent | 1 |
36 | encephalography | 1 |
37 | endogenous/psychotic | 2 |
38 | glucagon/insulin | 1 |
39 | grn+ | 5 |
40 | haemodialysis-dependent | 1 |
41 | hyperoxic-hypoxic | 1 |
42 | hypo-adiponectinemia | 1 |
43 | indo- | 1 |
44 | instable | 21 |
45 | interepisode | 4 |
46 | ionomycin/6-dimethylaminopurine | 1 |
47 | ipp=20mmhg | 1 |
48 | irbersartan | 1 |
49 | iss/8 | 1 |
50 | latrr | 1 |
51 | lay-facilitated | 4 |
52 | liver-cells | 1 |
53 | lt-4 | 1 |
54 | macrolide-recipients | 1 |
55 | magical-energetic | 1 |
56 | malaria-free | 7 |
57 | men1-related | 1 |
58 | mg-positive | 3 |
59 | motionless | 5 |
60 | nephrocardiovascular | 2 |
61 | non-dialysis-dependent | 33 |
62 | non-invalidating | 1 |
63 | non-resistant | 3 |
64 | noncongenital | 1 |
65 | nondialysis-requiring | 1 |
66 | nonequilibrated | 1 |
67 | nonmobile | 2 |
68 | nonrecruited | 1 |
69 | non–dialysis-requiring | 1 |
70 | ns3-r155k | 1 |
71 | oligo/amenorrhoea | 1 |
72 | one-vessel | 18 |
73 | overbidding | 1 |
74 | oxygen-permeable | 2 |
75 | pars-planitis | 1 |
76 | pbo/fin | 4 |
77 | phio | 1 |
78 | phospho-hsf1 | 1 |
79 | promus™ | 1 |
80 | quasi-equilibrium | 3 |
81 | r2-f. | 1 |
82 | rejection-free | 19 |
83 | renoparenchymal | 2 |
84 | risperi-done | 1 |
85 | scbc | 17 |
86 | second-reader | 2 |
87 | spirometry-defined | 1 |
88 | squatters | 1 |
89 | stabile | 7 |
90 | stable | 11,368 |
91 | subcapsulary | 1 |
92 | submsv | 13 |
93 | surgery-on | 1 |
94 | tempo/speed | 1 |
95 | tnfα-blockers | 1 |
96 | tocopherol-based | 1 |
97 | toraymyxin | 2 |
98 | unhealed | 24 |
99 | unstable/postinfarction | 1 |
100 | vasoproliferative | 2 |
101 | was-out | 1 |
102 | well-adjusted | 9 |
1 | grn+ | 5 |
2 | indo- | 1 |
3 | r2-f. | 1 |
4 | ccs≥10 | 1 |
5 | 474.63±108.50 | 1 |
6 | 13,880 | 1 |
7 | phospho-hsf1 | 1 |
8 | 34,912 | 1 |
9 | 11,292 | 1 |
10 | lt-4 | 1 |
11 | 277/465 | 1 |
12 | 2,856 | 4 |
13 | 5.08±2.76 | 1 |
14 | 193.19±68.96 | 1 |
15 | 2.84±2.07 | 1 |
16 | iss/8 | 1 |
17 | 1.15±0.59 | 1 |
18 | 44ca | 1 |
19 | oligo/amenorrhoea | 1 |
20 | hypo-adiponectinemia | 1 |
21 | scbc | 17 |
22 | magical-energetic | 1 |
23 | endogenous/psychotic | 2 |
24 | hyperoxic-hypoxic | 1 |
25 | a→c | 2 |
26 | 0g/d | 1 |
27 | 26-bed | 1 |
28 | tempo/speed | 1 |
29 | unhealed | 24 |
30 | spirometry-defined | 1 |
31 | controlled/cured | 3 |
32 | tocopherol-based | 1 |
33 | diet-alone-treated | 1 |
34 | effort-associated | 1 |
35 | men1-related | 1 |
36 | nonequilibrated | 1 |
37 | lay-facilitated | 4 |
38 | co-inherited | 3 |
39 | nonrecruited | 1 |
40 | well-adjusted | 9 |
41 | 4-chloro-3,5-dinitrobenzotrifluoride | 1 |
42 | 18f-fallypride | 1 |
43 | interepisode | 4 |
44 | malaria-free | 7 |
45 | rejection-free | 19 |
46 | bulk-like | 6 |
47 | oxygen-permeable | 2 |
48 | stable | 11,368 |
49 | instable | 21 |
50 | stabile | 7 |
51 | nonmobile | 2 |
52 | ionomycin/6-dimethylaminopurine | 1 |
53 | risperi-done | 1 |
54 | complicated/severe | 2 |
55 | early/severe | 2 |
56 | chronic-progressive | 5 |
57 | vasoproliferative | 2 |
58 | mg-positive | 3 |
59 | ipp=20mmhg | 1 |
60 | overbidding | 1 |
61 | nondialysis-requiring | 1 |
62 | non–dialysis-requiring | 1 |
63 | non-invalidating | 1 |
64 | cf3i | 1 |
65 | ns3-r155k | 1 |
66 | ebook | 1 |
67 | renoparenchymal | 2 |
68 | noncongenital | 1 |
69 | attagel | 1 |
70 | one-vessel | 18 |
71 | quasi-equilibrium | 3 |
72 | 200-µm | 2 |
73 | irbersartan | 1 |
74 | angiographically-proven | 2 |
75 | pbo/fin | 4 |
76 | glucagon/insulin | 1 |
77 | toraymyxin | 2 |
78 | surgery-on | 1 |
79 | unstable/postinfarction | 1 |
80 | phio | 1 |
81 | nephrocardiovascular | 2 |
82 | second-reader | 2 |
83 | latrr | 1 |
84 | pars-planitis | 1 |
85 | liver-cells | 1 |
86 | back-symptoms | 1 |
87 | tnfα-blockers | 1 |
88 | squatters | 1 |
89 | motionless | 5 |
90 | macrolide-recipients | 1 |
91 | caries-onset | 1 |
92 | non-resistant | 3 |
93 | elastase-dependent | 1 |
94 | dialysis-dependent | 36 |
95 | non-dialysis-dependent | 33 |
96 | haemodialysis-dependent | 1 |
97 | was-out | 1 |
98 | submsv | 13 |
99 | encephalography | 1 |
100 | subcapsulary | 1 |
101 | age-hardenability | 1 |
102 | promus™ | 1 |